[CH3:1][C@@H:2]1[CH2:6][O:5][C:4](=[O:7])[N:3]1[C:8]1[CH:16]=[CH:15][C:11]([C:12]([OH:14])=O)=[CH:10][CH:9]=1.[CH3:17][C:18]1[C:19]([N:28]2[CH2:33][CH2:32][NH:31][CH2:30][CH2:29]2)=[N:20][CH:21]=[C:22]([C:24]([F:27])([F:26])[F:25])[CH:23]=1.O.[Cl-].COC1N=C(OC)N=C([N+]2(C)CCOCC2)N=1.C(Cl)(Cl)[Cl:54]>O.CO>[ClH:54].[CH3:1][C@@H:2]1[CH2:6][O:5][C:4](=[O:7])[N:3]1[C:8]1[CH:9]=[CH:10][C:11]([C:12]([N:31]2[CH2:32][CH2:33][N:28]([C:19]3[C:18]([CH3:17])=[CH:23][C:22]([C:24]([F:27])([F:25])[F:26])=[CH:21][N:20]=3)[CH2:29][CH2:30]2)=[O:14])=[CH:15][CH:16]=1To a mixture of (R)-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid (664 mg) described in Preparation Example 37, 1-(3-methyl-5-trifluoromethylpyridin-2-yl)piperazine (736 mg) described in Preparation Example 51 and 4-(4,6-dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride hydrate (DMT-MM) (1.2 g) were added chloroform (5 mL) and methanol (5 mL), and the mixture was stirred at room temperature overnight. Water was added to the reaction mixture, and the mixture was extracted with chloroform. The organic layer was washed with saturated brine, and the solvent was evaporated. The residue was purified by column chromatography (hexane:ethyl acetate). The obtained compound was dissolved in ethyl acetate (20 mL), 4N hydrogen chloride/ethyl acetate (1 mL) was added, and the mixture was filtered to give the title compound (310 mg).